705 related articles for article (PubMed ID: 19489733)
1. The role of ubiquitin in NF-kappaB regulatory pathways.
Skaug B; Jiang X; Chen ZJ
Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
[TBL] [Abstract][Full Text] [Related]
2. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
Schmid JA; Birbach A
Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
[TBL] [Abstract][Full Text] [Related]
3. Dynamic protein complexes regulate NF-kappaB signaling.
Wegener E; Krappmann D
Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
[TBL] [Abstract][Full Text] [Related]
4. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes.
Karin M; Gallagher E
Immunol Rev; 2009 Mar; 228(1):225-40. PubMed ID: 19290931
[TBL] [Abstract][Full Text] [Related]
5. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
Scheidereit C
Oncogene; 2006 Oct; 25(51):6685-705. PubMed ID: 17072322
[TBL] [Abstract][Full Text] [Related]
6. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors.
Wullaert A; Heyninck K; Janssens S; Beyaert R
Trends Immunol; 2006 Nov; 27(11):533-40. PubMed ID: 16982211
[TBL] [Abstract][Full Text] [Related]
8. Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach.
Lee J; Choi K; Choi C
Biochem Biophys Res Commun; 2010 Jan; 391(1):33-7. PubMed ID: 19895789
[TBL] [Abstract][Full Text] [Related]
9. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
11. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
[TBL] [Abstract][Full Text] [Related]
12. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
[TBL] [Abstract][Full Text] [Related]
13. Activation of NF-kappaB by HTLV-I and implications for cell transformation.
Sun SC; Yamaoka S
Oncogene; 2005 Sep; 24(39):5952-64. PubMed ID: 16155602
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin signalling in the NF-kappaB pathway.
Chen ZJ
Nat Cell Biol; 2005 Aug; 7(8):758-65. PubMed ID: 16056267
[TBL] [Abstract][Full Text] [Related]
15. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
Fuchs O; Neuwirtová R
Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the pathway from the TCR to NF-kappaB.
Weil R; Israël A
Cell Death Differ; 2006 May; 13(5):826-33. PubMed ID: 16439988
[TBL] [Abstract][Full Text] [Related]
17. Good cop, bad cop: the different faces of NF-kappaB.
Perkins ND; Gilmore TD
Cell Death Differ; 2006 May; 13(5):759-72. PubMed ID: 16410803
[TBL] [Abstract][Full Text] [Related]
18. [Human pathologies associated with NF-kappaB defects].
Courtois G; Israël A
J Soc Biol; 2004; 198(2):93-6. PubMed ID: 15368956
[TBL] [Abstract][Full Text] [Related]
19. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
Perkins ND
Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]